REFERENCE
Matsuo K, Kiura K, Tabata M, Uchida A, Hotta K, Niiya D, Kubonishi S, Ogino A, Fujiwara Y, Nakajima H, Shinagawa K, Ishimaru F, Ueoka H, Tanimoto M.Clustered incidence of acute promyelocytic leukemia during gefitinib treatment for non-small-cell lung cancer: experience at a single institution. American Journal of Hematology 81: 349-354, No. 5, May 2006 - Japan
Rights and permissions
About this article
Cite this article
Gefitinib. React. Wkly. 1116, 15 (2006). https://doi.org/10.2165/00128415-200611160-00042
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200611160-00042